Lindsay Farrer, PhD
Professor
Boston University School of Medicine
Dept of Medicine
Biomedical Genetics

PhD, Indiana University School of Medicine



Dr. Lindsay Farrer is a medical geneticist at Boston University Schools of Medicine and Public Health where he is Chief of Biomedical Genetics and a Professor of Medicine, Neurology, Ophthalmology, Genetics & Genomics, Epidemiology, and Biostatistics. Dr. Farrer is a graduate of the University of North Carolina in Chapel Hill, received his Ph.D. from the Indiana University School of Medicine, and gained additional training in genetic epidemiology at Yale University. He holds adjunct faculty positions at Harvard Medical School, Massachusetts General Hospital, and the Veterans Administration Medical Center in Bedford, Massachusetts. He is a Founding Fellow of the American College of Medical Genetics. Dr. Farrer teaches several courses in human genetics and genetic epidemiology at Boston University, directs Boston University’s Molecular Genetics Core Facility which offers DNA genotyping and sequencing services to investigators at the Boston Medical Center, and provides genetic counseling and testing to patients with a variety of inherited conditions.

Dr. Farrer’s research has lead to more than 300 publications on genetic risk factors for several familial neurodegenerative and other chronic diseases. In collaboration with other laboratories worldwide, his group has localized genes causing a variety of rare and common disorders including Alzheimer disease (AD), Wilson disease, Machado-Joseph disease, Waardenburg syndrome, hypertension, sensorineural deafness, and osteoarthritis. His group identified a functional genetic variant in the complement factor H gene which accounts for more than 30% of the attributable risk for age-related macular degeneration (AMD), the leading cause of progressive vision loss and blindness in the elderly. In collaboration with other researchers, Dr. Farrer is conducting genome wide association studies (GWAS) for several disorders including AD, substance dependence (cocaine, opiates, nicotine and alcohol), AMD and vasculitis. Dr. Farrer’s team is also developing methods for locating genes that influence the natural history of complex diseases and pharmacogenetic response.

Under Dr. Farrer’s leadership, the MIRAGE Project, a multi-center study of AD funded since 1991 by the National Institute on Aging, has made several important contributions to our understanding of the interactions between genetic and environmental factors for the disorder. This study has a particular emphasis on the genetics of AD in African Americans. Thus far, detailed family histories, risk factor data, and DNA specimens from more than 2,500 AD families have been collected as a part of this program. MIRAGE was the first study to demonstrate that genetic factors have a major role in the development of AD and that APOE e4 is more weakly associated with disease in men and persons older than 75 years. Dr. Farrer co-directed the international effort which demonstrated that SORL1 is genetically and functionally associated with AD, thus implicating intracellular protein trafficking as integral pathway in AD. His laboratory conducted genome wide association studies (GWAS) for AD in several populations including African Americans and an inbred Israeli-Arab community. Dr. Farrer serves on the Executive Committee of the national Alzheimer Disease Genetics Consortium and co-directs the data analysis effort for this large NIH-funded project. He and his colleagues recently discovered four new Alzheimer genes in the largest GWAS of AD to date.

Section Chief
Boston University School of Medicine
Medicine
Biomedical Genetics

Boston University Distinguished Professor of Genetics
Boston University School of Medicine
Medicine
Biomedical Genetics

Professor
Boston University School of Medicine
Ophthalmology


Professor
Boston University School of Medicine
Neurology


Professor
Boston University School of Public Health
Biostatistics


Professor
Boston University School of Public Health
Epidemiology


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences


Member
Boston University
Bioinformatics Graduate Program




Genomic and Biological Studies of APOE E2 in Alzheimer's Disease
09/15/2017 - 06/30/2022 (PI)
NIH/National Institute on Aging
1RF1AG057519-01

Institutional Program Unifying Population and Laboratory Based Sciences Award
02/01/2013 - 01/31/2019 (PI)
Burroughs Wellcome Fund


Genetics of Opioid Dependence
09/01/2016 - 08/31/2018 (PI)
Yale University NIH NIDA
4R01DA012690-14

Consortium for Alzheimer Sequencing and Analysis (CASA)
06/15/2014 - 05/31/2018 (PI)
Trustees of the University of Pennsylvan NIH NIA
1UF1AG047133-01

Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing
05/01/2017 - 03/31/2018 (PI)
Yale University NIH NIDA
5R01DA037974-03

Alzheimer's Disease Genetics Consortium
06/15/2015 - 03/31/2018 (PI)
Trustees of the University of Pennsylvan NIH NIA
5U01AG032984-07

Coordinating Center for Genetics and Genomics of Alzheimer's Disease
04/15/2016 - 02/28/2018 (PI)
Trustees of the University of Pennsylvan NIH NIA
5U54AG052427-02

Coordinating Center for Genetics and Genomics of Alzheimer's Disease
04/15/2016 - 02/28/2018 (PI)
Trustees of the University of Pennsylvan NIH NIA
5U54AG052427-02

Alzheimer Disease Genetic Architecture in African Americans
02/15/2015 - 01/31/2018 (PI)
NIH/National Institute on Aging
5R01AG048927-03

Analysis of Genetic Data for refractive error and Myopia
05/01/2014 - 04/30/2017 (PI)
Trustees of the University of Pennsylvan NIH NEI
5R01EY024233-03

Showing 10 of 30 results. Show All Results



Yr Title Project-Sub Proj Pubs
2017 Genomic and Biological Studies of APOE ?2 in Alzheimer Disease 1RF1AG057519-01
2017 Alzheimer Disease Genetic Architecture in African Americans 5R01AG048927-03 1
2016 Alzheimer Disease Genetic Architecture in African Americans 5R01AG048927-02 1
2016 Alzheimer Disease Genetic Architecture in African Americans 3R01AG048927-02S1 1
2015 Alzheimer Disease Genetic Architecture in African Americans 1R01AG048927-01 1
2014 Consortium for Alzheimers Sequence Analysis (CASA) 1UF1AG047133-01 2
2010 Multi-ethnic Genome-wide Alzheimer association study 5R01AG025259-05 42
2009 Multi-ethnic genome-wide Alzheimer association study 5R01AG025259-04 42
2008 Multi-ethnic genome-wide Alzheimer's association study 5R01AG025259-03 42
2007 GENETIC EPIDEMIOLOGICAL STUDIES OF ALZHEIMER'S DISEASE 2M01RR000533-39-8138 429
Showing 10 of 45 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Chung J, Wang X, Maruyama T, Ma Y, Zhang X, Mez J, Sherva R, Takeyama H, Lunetta KL, Farrer LA, Jun GR. Genome-wide association study of Alzheimer''s disease endophenotypes at prediagnosis stages. Alzheimers Dement. 2017 Dec 20.View Related Profiles. PMID: 29274321.
  2. Tielbeek JJ, Johansson A, Polderman TJC, Rautiainen MR, Jansen P, Taylor M, Tong X, Lu Q, Burt AS, Tiemeier H, Viding E, Plomin R, Martin NG, Heath AC, Madden PAF, Montgomery G, Beaver KM, Waldman I, Gelernter J, Kranzler HR, Farrer LA, Perry JRB, Munafò M, LoParo D, Paunio T, Tiihonen J, Mous SE, Pappa I, de Leeuw C, Watanabe K, Hammerschlag AR, Salvatore JE, Aliev F, Bigdeli TB, Dick D, Faraone SV, Popma A, Medland SE, Posthuma D. Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior. JAMA Psychiatry. 2017 Dec 01; 74(12):1242-1250. PMID: 28979981.
  3. Zhou H, Polimanti R, Yang BZ, Wang Q, Han S, Sherva R, Nuñez YZ, Zhao H, Farrer LA, Kranzler HR, Gelernter J. Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression. JAMA Psychiatry. 2017 Dec 01; 74(12):1234-1241.View Related Profiles. PMID: 29071344.
  4. Polimanti R, Amstadter AB, Stein MB, Almli LM, Baker DG, Bierut LJ, Bradley B, Farrer LA, Johnson EO, King A, Kranzler HR, Maihofer AX, Rice JP, Roberts AL, Saccone NL, Zhao H, Liberzon I, Ressler KJ, Nievergelt CM, Koenen KC, Gelernter J. A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder. Genome Med. 2017 Nov 27; 9(1):99. PMID: 29178946.
  5. Farrer LA, DeAngelis MM. Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degeneration. Stem Cell Investig. 2017; 4:92. PMID: 29270418.
  6. Agrawal A, Chou YL, Carey CE, Baranger DAA, Zhang B, Sherva R, Wetherill L, Kapoor M, Wang JC, Bertelsen S, Anokhin AP, Hesselbrock V, Kramer J, Lynskey MT, Meyers JL, Nurnberger JI, Rice JP, Tischfield J, Bierut LJ, Degenhardt L, Farrer LA, Gelernter J, Hariri AR, Heath AC, Kranzler HR, Madden PAF, Martin NG, Montgomery GW, Porjesz B, Wang T, Whitfield JB, Edenberg HJ, Foroud T, Goate AM, Bogdan R, Nelson EC. Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry. 2017 Nov 07.View Related Profiles. PMID: 29112194.
  7. Beecham GW, Bis JC, Martin ER, Choi SH, DeStefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE, Naj AC, Psaty BM, Salerno W, Bush WS, Foroud TM, Wijsman E, Farrer LA, Goate A, Haines JL, Pericak-Vance MA, Boerwinkle E, Mayeux R, Seshadri S, Schellenberg G. The Alzheimer''s Disease Sequencing Project: Study design and sample selection. Neurol Genet. 2017 Oct; 3(5):e194.View Related Profiles. PMID: 29184913.
  8. Polimanti R, Zhao H, Farrer LA, Kranzler HR, Gelernter J. Ancestry-specific and sex-specific risk alleles identified in a genome-wide gene-by-alcohol dependence interaction study of risky sexual behaviors. Am J Med Genet B Neuropsychiatr Genet. 2017 Dec; 174(8):846-853. PMID: 28990359.
  9. Rehker J, Rodhe J, Nesbitt RR, Boyle EA, Martin BK, Lord J, Karaca I, Naj A, Jessen F, Helisalmi S, Soininen H, Hiltunen M, Ramirez A, Scherer M, Farrer LA, Haines JL, Pericak-Vance MA, Raskind WH, Cruchaga C, Schellenberg GD, Joseph B, Brkanac Z. Caspase-8, association with Alzheimer''s Disease and functional analysis of rare variants. PLoS One. 2017; 12(10):e0185777. PMID: 28985224.
  10. Hancock DB, Guo Y, Reginsson GW, Gaddis NC, Lutz SM, Sherva R, Loukola A, Minica CC, Markunas CA, Han Y, Young KA, Gudbjartsson DF, Gu F, McNeil DW, Qaiser B, Glasheen C, Olson S, Landi MT, Madden PAF, Farrer LA, Vink J, Saccone NL, Neale MC, Kranzler HR, McKay J, Hung RJ, Amos CI, Marazita ML, Boomsma DI, Baker TB, Gelernter J, Kaprio J, Caporaso NE, Thorgeirsson TE, Hokanson JE, Bierut LJ, Stefansson K, Johnson EO. Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. Mol Psychiatry. 2017 Oct 03.View Related Profiles. PMID: 28972577.
Showing 10 of 423 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 423 publications over 34 distinct years, with a maximum of 28 publications in 2011 and 2013

YearPublications
19841
19857
19865
198710
19886
19898
19906
19918
199212
19939
199411
199511
199610
19978
199811
19999
20007
20018
20026
200311
20045
200520
200616
200713
200811
200916
201013
201128
201220
201328
201421
201527
201615
201726
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

age-related macular degeneration
Alzheimer disease
gene mapping
genetic epidemiology
illicit drug dependence

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Farrer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department